The case against using 5-aminosalicyclates in Crohn's disease: con
- PMID: 15905711
- DOI: 10.1097/01.mib.0000160745.09525.74
The case against using 5-aminosalicyclates in Crohn's disease: con
Comment on
-
Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.Inflamm Bowel Dis. 2005 Jun;11(6):616-7. doi: 10.1097/01.mib.0000160744.32396.02. Inflamm Bowel Dis. 2005. PMID: 15905712
Similar articles
-
The case for using 5-aminosalicyclates in Crohn's disease: pro.Inflamm Bowel Dis. 2005 Jun;11(6):609-12. doi: 10.1097/01.mib.0000160743.24772.69. Inflamm Bowel Dis. 2005. PMID: 15905710
-
Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.Curr Gastroenterol Rep. 1999 Oct;1(5):377-83. doi: 10.1007/s11894-999-0018-2. Curr Gastroenterol Rep. 1999. PMID: 10980975 Review.
-
Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.Inflamm Bowel Dis. 2005 Jun;11(6):616-7. doi: 10.1097/01.mib.0000160744.32396.02. Inflamm Bowel Dis. 2005. PMID: 15905712
-
[Improved treatment of Crohn's disease].Rev Med Suisse. 2005 May 4;1(18):1241. Rev Med Suisse. 2005. PMID: 15977716 French. No abstract available.
-
Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.Eur J Surg. 1998 Dec;164(12):903-9. doi: 10.1080/110241598750005066. Eur J Surg. 1998. PMID: 10029385 Review. No abstract available.
Cited by
-
Management of Crohn's disease - are guidelines transferred to clinical practice?United European Gastroenterol J. 2015 Aug;3(4):371-80. doi: 10.1177/2050640615580228. United European Gastroenterol J. 2015. PMID: 26279846 Free PMC article.
-
Traditional corticosteroids for induction of remission in Crohn's disease.Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD006792. doi: 10.1002/14651858.CD006792.pub2. Cochrane Database Syst Rev. 2008. PMID: 18425970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical